亚太地区起搏器市场至 2027 年 - 按产品类型(植入式起搏器、体外起搏器)、按技术(单腔、双腔和双心室)、最终用户(医院、门诊手术中心等)进行区域分析和预测,和国家

Historic Data: 2016-2017   |   Base Year: 2018   |   Forecast Period: 2019-2027


No. of Pages: 133    |    Report Code: TIPRE00006297    |    Category: Life Sciences

Asia Pacific Pacemakers Market

亚太起搏器市场预计将从 2018 年的 10.305 亿美元增至 2027 年的 22.427 亿美元。预计从 2019 年开始,该市场将以 9.2% 的复合年增长率增长 - 2027 年。

 

亚太地区的增长特点是老年人口、心血管疾病发病率增加、久坐的生活方式、先进技术的普及、创新和技术先进产品的不断开发以及医疗保健支出的增加

 

该地区日益增长的肥胖也可能引发心血管疾病。马来西亚的肥胖率在东南亚地区最高,为 14%%,其次是泰国,为 8.8%。此外,澳大利亚和新西兰的肥胖率分别为26.8%和28.3%%。此外,不健康的饮食正在导致营养过剩和肥胖。亚太地区一些国家正在观察快餐的影响。根据联合国儿童基金会2013年的报告,估计东亚太平洋地区有1100万5岁以下儿童超重。因此,这些因素导致心血管疾病的增长,并最终导致起搏器市场的增长。

 

此外,2016年至2019年期间,各公司在其运营的市场上制定了有机和无机增长战略。该公司开展的一些促进其发展的活动包括产品发布、收购和合作。有机发展战略的不断实施,促进了企业的成长,也带来了市场的各种变化。例如,2018年5月,中国制造商乐普医疗科技(北京)有限公司通过海外子公司乐普康(印度)血管解决方案将业务拓展至印度市场。乐普医疗科技(北京)有限公司通过子公司进入印度市场,并可能探索本地制造和合作的机会。

 

由于老年人口的增加以及日本主要市场参与者推出的产品等因素,预计日本在预测期内将出现增长,这可能会促进起搏器市场在预测期内的增长.

 

 

< span>

亚太起搏器市场–市场细分

 

亚太起搏器市场–按

产品

类型

  • 植入式起搏器
  • 体外起搏器

亚太地区起搏器市场 -按技术

  • 单室
  • 双室
  • < li>双心室

亚太地区起搏器市场 -由

最终用户

  • 医院和医院诊所
  • 门诊手术中心
  • 家庭护理

 

按地理位置

•  亚太地区

  • 印度
  • 中国
  • 日本
  • 澳大利亚
  • 韩国

 

公司简介

  • 美敦力
  • 雅培
  • 百多力
  • LivaNova Plc
  • 波士顿科学公司
  • 乐普医疗
  • MEDICO SpA
  • < span>Vitatron Holding BV
  • OSCOR Inc
  • Pacetronix


Asia Pacific Pacemakers Strategic Insights

Strategic insights for Asia Pacific Pacemakers involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-pacemakers-market-strategic-framework.webp
Get more information on this report

Asia Pacific Pacemakers Report Scope

Report Attribute Details
Market size in 2018 US$ 1,030.5 Million
Market Size by 2027 US$ 2,242.7 Million
Global CAGR (2019 - 2027) 9.2%
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By 产品类型
  • 植入式起搏器
  • 体外起搏器
By 技术
  • 单腔
  • 双腔
  • 双心室
By 最终用户
  • 医院
  • 门诊手术中心
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Medtronic
  • Abbott
  • BIOTRONIK
  • LivaNova Plc.
  • Boston Scientific Corporation
  • Lepu Medical
  • MEDICO S.p.A.
  • Vitatron Holding B.V.
  • OSCOR Inc
  • Pacetronix
  • Get more information on this report

    Asia Pacific Pacemakers Regional Insights

    The regional scope of Asia Pacific Pacemakers refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-pacemakers-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Pacemakers Market

    The List of Companies

    1. Medtronic
    2. Abbott
    3. BIOTRONIK
    4. LivaNova Plc.
    5. Boston Scientific Corporation
    6. Lepu Medical
    7. MEDICO S.p.A.
    8. Vitatron Holding B.V.
    9. OSCOR Inc
    10. Pacetronix

     

    Frequently Asked Questions
    How big is the Asia Pacific Pacemakers Market?

    The Asia Pacific Pacemakers Market is valued at US$ 1,030.5 Million in 2018, it is projected to reach US$ 2,242.7 Million by 2027.

    What is the CAGR for Asia Pacific Pacemakers Market by (2019 - 2027)?

    As per our report Asia Pacific Pacemakers Market, the market size is valued at US$ 1,030.5 Million in 2018, projecting it to reach US$ 2,242.7 Million by 2027. This translates to a CAGR of approximately 9.2% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Pacemakers Market report typically cover these key segments-

  • 产品类型 (植入式起搏器, 体外起搏器)
  • 技术 (单腔, 双腔, 双心室)
  • 最终用户 (医院, 门诊手术中心)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Pacemakers Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Pacemakers Market report:

  • Historic Period : 2016-2017
  • Base Year : 2018
  • Forecast Period : 2019-2027
  • Who are the major players in Asia Pacific Pacemakers Market?

    The Asia Pacific Pacemakers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Medtronic
  • Abbott
  • BIOTRONIK
  • LivaNova Plc.
  • Boston Scientific Corporation
  • Lepu Medical
  • MEDICO S.p.A.
  • Vitatron Holding B.V.
  • OSCOR Inc
  • Pacetronix
  • Who should buy this report?

    The Asia Pacific Pacemakers Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Pacemakers Market value chain can benefit from the information contained in a comprehensive market report.